factual

Pharma Consolidation Creates Moats via Manufacturing

Pharma is only about 10 percent of health care spending yet spends roughly 20 percent of sales on R&D, and its manufacturing complexity creates a moat that blocks generics even after patents expire, as with Vertex in cystic fibrosis.

factualpending

Speaker

Anne-Marie Peterson

Evidence Quote

“there's a moat for generics, which is the manufacturing.”

Source

Anne-Marie Peterson - The Capital System - [Invest Like the Best, EP.364]— Invest Like the Best
Created: 11/14/2026, 4:41:01 AM

Your notes

Loading notes...